15 Best Small-Cap Healthcare Stocks to Buy
The term small cap can be used to define established companies with a small market capitalization ranging anywhere between $300 million and $2 billion.
Posts Tagged ‘Vanda Pharmaceuticals Inc. (VNDA)’
13G Filing: Armistice Capital and Vanda Pharmaceuticals Inc. (VNDA)
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent...
Vanda Pharmaceuticals Inc. (VNDA) Stock: Deerfield Management Cashes In 2.56 Million Shares
According to a freshly-amended 13G filing with the Securities and Exchange Commission, James E.
Here’s Why Traders Are Buzzing about These Five Stocks
Fading chances of a rate hike soothed the market sentiment on Wednesday.
Smart Money Is Seeing Upside For These Three Companies
According to a recent filing with the SEC, Christopher Sackelton and Adam Grey's Coliseum Capital has acquired some 2.74 million shares of Universal Technical Institute, Inc...
These Five Biotech Stocks Ranked Among This UK-based Fund’s Favorites
Cheyne Capital is one of the few non-U.S firms that we track in our database.
Stonepine Capital Management Reveals 5.5% Stake in Vanda Pharmaceuticals Inc. (VNDA)
In a new filing with the Securities and Exchange Commission, Stonepine Capital Management disclosed a passive stake in Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc (VNDA): Deerfield Management Increases Exposure Following Positive Announcement
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday.
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.
Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): This Week in Biotech
With the SPDR S&P Biotech Index up 43% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Sanofi SA (ADR) (SNY), Vanda Pharmaceuticals Inc. (VNDA), Merck & Co., Inc. (MRK) – Sleep War Z: A Written History of the Insomniac War
It’s estimated that 30% to 40% of adults in the world experience some degree of insomnia every year. Most of these cases aren’t chronic and do not require medication.
Micron Technology, Inc. (MU) Calls Change Hands At A Clip Ahead of Earnings After The Close
Micron Technology, Inc. (NASDAQ:MU) – Options traders appear to be snapping up out of the money call options on Micron Technology, Inc.
Discovery Laboratories, Inc. (DSCO): Are Hedge Funds Right About This Stock?
Is Discovery Laboratories, Inc. (NASDAQ:DSCO) a healthy stock for your portfolio? Investors who are in the know are getting less optimistic.
Assessing Raptor Pharmaceutical Corp. (RPTP)’s Agreement With HealthCare Royalty Partners
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) signed an agreement with HealthCare Royalty Partners.
Bristol Myers Squibb Co (BMY), Momenta Pharmaceuticals, Inc. (MNTA): White Collar Criminals Love Biotech Stocks
It's understandably very tempting for people with inside information to trade biotech stocks.
This Metric Says You Are Smart to Buy Vanda Pharmaceuticals Inc. (VNDA)
In the 21st century investor’s toolkit, there are many indicators shareholders can use to watch the equity markets.
Is Complete Genomics, Inc. (GNOM) Going to Reward These Hedge Funds?
Complete Genomics, Inc. (NASDAQ:GNOM) was in 9 hedge funds' portfolio at the end of the fourth quarter of 2012.
Oncothyreon Inc (USA) (ONTY): Are Hedge Funds Right About This Stock?
Oncothyreon Inc (USA) (NASDAQ:ONTY) was in 9 hedge funds' portfolio at the end of the fourth quarter of 2012.
Avoid This Biotech Stock: Chelsea Therapeutics International Ltd. (CHTP)
Editor's note: This article is a stock pitch made by a member on CAPS, The Motley Fool's free investing community.
